Interius BioTherapeutics

Philadelphia, PA · Founded 2019 · Privately Held (backing)

Developer of a genetic medicines precision delivery platform intended to treat hematologic malignancies. Interius BioTherapeutics is based in Philadelphia, PA and was founded in 2019. It was valued at $350 million at a merger or acquisition in Oct 2025, the last priced event on record. It has raised $170 million across 4 recorded rounds; the latest was a $51.4 million later-stage round in May 2024.

PMV mark · valuation
$350.0M
Oct 2026
Priced at
a merger or acquisition
Oct 2025
Total raised
$169.6M
Last round
Later Stage VC
May 2024
How much has Interius BioTherapeutics raised?
$169.6Macross 4 recorded rounds · Mar 2020 – May 2024

Most recently, Interius BioTherapeutics raised $51.4M in its Later Stage VC (May 2024).

Free account
More of Interius BioTherapeutics with a free account
  • ·The complete investor list: 20 names
  • ·Watch Interius BioTherapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Interius BioTherapeutics round by round

4 rounds
May 2024Later Stage VC$51.4MSEC filing▮
12 investors participated
Oct 2023Debt$21.5MSEC filing▮
13 investors participated
May 2021Early Stage VC$43.6MSEC filing▮
25 investors participated
Mar 2020Seed Round$1.6MSEC filing▮
5 investors participated

How much has Interius BioTherapeutics raised?

Interius BioTherapeutics has raised $170 million across 4 recorded rounds since 2020. The largest was a $51.4 million later-stage round in May 2024.

Interius BioTherapeutics has filed 4 Form Ds with the SEC since 2020, most recently in Jun 2024 ($51.4 million sold to 12 investors).

Interius BioTherapeutics investors

20 investors are on record for Interius BioTherapeutics, including Osage University Partners, Cormorant Asset Management, Pfizer Ventures and Logos Capital. By type, the record holds 4 venture capital firms and 1 hedge fund. The later-stage round in May 2024 drew 12 investors.

For fundraisers
Raising for a company like Interius BioTherapeutics?

20 investors have backed Interius BioTherapeutics.

See all 20 investors →

Frequently asked about Interius BioTherapeutics

How much has Interius BioTherapeutics raised?
Interius BioTherapeutics has raised $169.6M in total across 4 recorded funding rounds.
When was Interius BioTherapeutics's last funding round?
Interius BioTherapeutics's most recent recorded round was Later Stage VC in May 2024, raising $51.4M.